Wenyan Fu
28 Fuxing Road
Beijing, 100853, China
Beijing, 100853, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Bispecific MASP-2/3 antibody provides superior renoprotection over monotherapy in pristane-induced lupus nephritis.
Journal: Clinical and experimental immunology
Published: January 11, 2026
Development of CAR Exosomes Targeting FAP for the Treatment of Intrauterine Adhesion.
Journal: Journal of extracellular vesicles
Published: November 03, 2025
Protective effects of an Fc-engineered PD-L1 fusion protein in a spontaneous abortion model and a Th17 cell-induced pregnancy loss model.
Journal: Frontiers in pharmacology
Published: September 21, 2025
Antibody screening for tumor and immune hotspot targets: The frontier of new methods and technologies.
Journal: Journal of pharmaceutical analysis
Published: October 24, 2024
T-Cell-Dependent Bispecific IgGs Protect Aged Mice From Lethal SARS-CoV-2 Infection.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 22, 2024
Exosomes: the next frontier in vaccine development and delivery.
Journal: Frontiers in immunology
Published: May 20, 2024
The therapeutic potential of exosomes in immunotherapy.
Journal: Frontiers in immunology
Published: April 27, 2024
Small extracellular vesicles purification and scale-up.
Journal: Frontiers in immunology
Published: November 26, 2023
The application of antibody-based agents in cancer therapy based on their mechanisms of action.
Journal: Fundamental research
Published: November 11, 2023
Bispecific antibodies targeting EGFR/Notch enhance the response to talazoparib by decreasing tumour-initiating cell frequency.
Journal: Theranostics
Published: December 25, 2022
Engineered soluble ACE2 receptor: Responding to change with change.
Journal: Frontiers in immunology
Published: October 30, 2022
Last Updated: 09/26/2026